James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

3 Big Stock Charts for Thursday: Tiffany & Co., Arconic and Regions Financial

The stock charts of Tiffany & Co., Arconic and Regions Financial have earned a closer look as we head into the end of the trading week.

Even with This Dip, There’s No Good Reason to Buy Nio Stock

Nio stock looks like a bargain at near-record lows, but this EV company is still struggling to find its place following its IPO.

3 Big Stock Charts for Wednesday: eBay, UnitedHealth and Berkshire Hathaway

The stock charts of EBAY, UNH and BRK.B have run through the trading wringer in the shadow of the market's stumble.

Looming Goodwill Growth Makes CRON Stock Tough to Handicap

CRON stock has been popular because Cronos hasn't been on a rampant acquisition spree. But, that could be about to change.

3 Big Stock Charts for Tuesday: TechnipFMC PLC, Vertex Pharmaceuticals and Constellation Brands

The stock charts of FTI, VRTX and STZ are knocking on the doors of major moves, even if the broad market isn't.